|
T.TH
|
I would point out a company likely has some flexibility in determining the...
|
|
T.TH
|
If you are letting yourself be sidetracked by the cartoonish trading in the...
|
|
T.TH
|
There are other competitors either already in the space or soon to be - GILD...
|
|
T.TH
|
With the last patient in the IM trial expected in November 2022, you are...
|
|
T.TH
|
It at least gives them an excuse to get in front of more key clinic people to...
|
|
T.TH
|
Only an exaggerated, and quite brief, market reaction as a result of our new...
|
|
T.TH
|
Clearly, Zip Trader tourists to TH think we should have had a PR already...
|
|
T.TH
|
It was supposed to be resolved in early October. What might TH say about this...
|
|
T.TH
|
If you are asking for full phase 1b data before 10/13, you don't...
|
|
T.TH
|
THTX spent the month of September getting out and telling their story...
|
|
T.TH
|
It is not possible chemically to turn Egrifta into a pill. PWIB123 wrote: We...
|
|
T.TH
|
We "think" we have the key is not the same as we "know"...
|
|
T.TH
|
I can pull up a page on Bloomberg and see options activity and open interest....
|
|
T.TH
|
The crazy thing is if he had just done a little homework forst, the truth...
|
|
T.TH
|
Once the retail crowd is engaged, they can stick around for a while as they...
|
|
T.TH
|
Another possible explantion is TH met with some institution very early...
|
|
T.TH
|
High minded stubborness. But I do have some sympathy for them on this as it...
|
|
T.TH
|
Good point - May the buyer always be aware as they possibly can to all the...
|
|
T.TH
|
The old line that there is no such thing as bad publicity certainly applies...
|
|
T.TH
|
I really, really doubt TH had anything to do with this. TH can get...
|